Using LUAD tissues and clinical samples, we showed that SERPINH1 can be used as a prognostic biomarker for LUAD. Our findings provide a new approach and strategy for the clinical treatment of LUAD patients.
2 months ago
Journal • Tumor mutational burden • IO biomarker
TMB (Tumor Mutational Burden) • SERPINH1 (Serpin family H member 1)